The National Taskforce for Combating the Coronavirus (COVID-19) yesterday held a press conference to highlight measures taken to mitigate the spread of COVID-19.
In this regard, Dr. Waleed Khalifa Al Manea, Undersecretary at the Ministry of Health noted that the ministry has announced the initiation of a phase III clinical trial for a COVID-19 inactivated vaccine.
The trial will enlist up to 6000 volunteers who have not previously contracted COVID-19, are over the age of 18, and are willing to undergo a health assessment, in accordance with set health requirements.
Turning to patient outcome, Dr. Al Manea explained that the recovery rate is currently at 92.6% with a 0.4% death rate. Isolation centre capacity stands at 21%, with 1,752 out of 8,357 beds occupied, and 1,383 asymptotic cases are under optional home self-isolation after meeting the set criteria.